<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02809144</url>
  </required_header>
  <id_info>
    <org_study_id>0472</org_study_id>
    <nct_id>NCT02809144</nct_id>
  </id_info>
  <brief_title>A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery</brief_title>
  <official_title>A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interscalene block has been the traditional regional anesthesia for shoulder surgery and&#xD;
      postoperative pain. However, the risk of phrenic nerve palsy and irreversible nerve injury&#xD;
      have encouraged search for alternative methods.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Analyzing block effects of the lateral sagittal infraclavicular brachial plexus&#xD;
      block(posterior and lateral chord), the investigators found it affecting all shoulder&#xD;
      relevant nerves , except for the suprascapular and the supraclavicular nerves.&#xD;
&#xD;
      Accordingly, by combining a superficial cervical plexus block, suprascapular nerve block and&#xD;
      block of the posterior and lateral chords infraclavicularly, the investigators believe this&#xD;
      novel combination would provide anesthesia for patients scheduled for shoulder surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The need for general anaesthesia</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Investigators will record the number of patients who need to be converted to general anaesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgeons satisfaction with the working conditions</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Graded in a) Good and b) Poor</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Nerve block</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>One novel nerve block combination</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nerve block</intervention_name>
    <description>Nerve block: 31 ml ropivacaine 7.5 mg/ml (Lateral sagittal infraclavicular brachial plexus block) + 4 ml ropivacaine 5 mg/ml (suprascapular nerve block) + 5 ml ropivacaine 5 mg/ml (superficial cervical plexus block)</description>
    <arm_group_label>Nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for shoulder surgery.&#xD;
&#xD;
          -  American Society of Anesthesiologist grad I-III,&#xD;
&#xD;
          -  18-70 years,&#xD;
&#xD;
          -  BMI 20-35,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy,&#xD;
&#xD;
          -  coagulopathy,&#xD;
&#xD;
          -  allergy to local anesthetics,&#xD;
&#xD;
          -  atrioventricular block,&#xD;
&#xD;
          -  peripheral neuropathy or drug-treated diabetes.&#xD;
&#xD;
          -  Patients using anticoagulation other than acetylsalicylic acid or dipyridamol will be&#xD;
             excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Marius Ytrebø, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of North Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsø</city>
        <state>Troms</state>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>May 25, 2015</study_first_submitted>
  <study_first_submitted_qc>June 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2016</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of North Norway</investigator_affiliation>
    <investigator_full_name>Lars Marius Ytrebo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

